|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||
| Investments, at fair value | ||||||||||||||||
| Non-controlled/non-affiliated | ||||||||||||||||
| Non-controlled/affiliated | ||||||||||||||||
| Controlled/affiliated | ||||||||||||||||
| Total investments, at fair value | ||||||||||||||||
| Cash, cash equivalents and restricted cash | ||||||||||||||||
| Receivable for investments sold | ||||||||||||||||
| Deferred financing costs | ||||||||||||||||
| Interest and dividend receivable | ||||||||||||||||
| Derivative assets, at fair value (Note 8) | ||||||||||||||||
| Prepaid expenses and other assets | ||||||||||||||||
| Total assets | ||||||||||||||||
| LIABILITIES | ||||||||||||||||
| Secured borrowings (Note 7) | ||||||||||||||||
| Debt and secured borrowings (Note 9) | ||||||||||||||||
| Payable for investments purchased | ||||||||||||||||
| Interest and credit facility fees payable (Note 9) | ||||||||||||||||
| Dividend payable (Note 11) | ||||||||||||||||
| Base management and incentive fees payable (Note 4) | ||||||||||||||||
| Administrative service fees payable (Note 4) | ||||||||||||||||
| Derivative liabilities, at fair value (Note 8) | ||||||||||||||||
| Other accrued expenses and liabilities | ||||||||||||||||
| Total liabilities | ||||||||||||||||
| NET ASSETS | ||||||||||||||||
| Cumulative convertible preferred stock, $0.01 par value; 0 and 2,000,000 shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively | ||||||||||||||||
| Common stock, $0.01 par value; 198,000,000 shares authorized; 69,160,814 and 71,807,190 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||
| Paid-in capital in excess of par value | ||||||||||||||||
| Offering costs | ||||||||||||||||
| Total distributable earnings (loss) | ||||||||||||||||
| Total net assets | ||||||||||||||||
| NET ASSETS PER COMMON SHARE (in dollars per share) | ||||||||||||||||
| Preferred stock, par value (in dollars per share) | ||||||||||||||||
| Preferred stock, issued (in shares) | ||||||||||||||||
Loading...
